Working… Menu

A Study to Evaluate the Safety, Tolerability and Efficacy of ILB in Patients With Amyotrophic Lateral Sclerosis

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT03613571
Recruitment Status : Terminated (13 of 15 patients recruited.Study patients responded with no safety signals. Recruitment slow,timely end of study necessary to keep development timelines)
First Posted : August 3, 2018
Last Update Posted : September 19, 2019
Information provided by (Responsible Party):
TikoMed AB

No Study Results Posted on for this Study
Recruitment Status : Terminated
Actual Primary Completion Date : August 20, 2019
Actual Study Completion Date : August 20, 2019